Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Tuesday, September 15, 2026

Snapshot: Sep 15, 2026 · 6:00 PM 100 stocks analyzed

Strong Down Day

Tue, Sep 15, 2026 Broad Selloff High

Broad selloff hammered equities with Russell 2000 down 3%, healthcare collapsing, yet pockets of explosive biotech and AI rallies amid extreme single-stock dispersion.

55% Market suffered a broad-based selloff with S&P 500 down 1.14%, Nasdaq down 1.66%, and Russell 2000 plunging 3.04%—a capitulation day where mid-caps and small-caps bore the brunt while VIX rose 4.5%, signaling renewed risk-off sentiment across all asset classes.
30% Healthcare sector dominated the losers list at 36% concentration, with major declines in biotech and pharma, yet counterintuitively also held 24% of gainers, revealing extreme dispersion and a tale of two healthcare narratives: clinical trial failures versus pipeline breakthroughs and financing wins.
15% High dispersion reached 50 gainers averaging +20.6% gains led by ROC (+69.7%), PDSB (+48% on Dr. Soon-Shiong backing), and TPST/VRA/WAFU hitting +35% to +39% on news-driven catalysts, while 50 losers averaged -29.9% with HCMA collapsing 98% and FEED down 77%, reflecting a stock-pickers battlefield where selection skill mattered more than beta.

Healthcare drove 36% of losers 5 names returned after long absences BENF · 4-day losers streak RBOT · 4-day losers streak TPST — first appearance VRA — first appearance

Market Regime

Tue, Sep 15, 2026 Neutral conf: medium macro · prototype

-23

Headwind −100 … +100 · + tailwind / − headwind

VIX17.2 p68 Drawdown-2.7% Held3d · building SinceSep 11

Top drivers: VIX percentile ▼ Small-cap leadership ▼ S&P vs 20d avg ▼

processId: history-market-regime

Market Indexes

Tue, Sep 15, 2026 13

S&P 500

7,585.73

−87.79

-1.14%

Dow Jones

52,093.11

−692.96

-1.31%

NASDAQ Composite

25,981.57

−439.84

-1.66%

NASDAQ 100

28,937.84

−569.86

-1.93%

DJ US Total Market

74,905.92

−990.15

-1.30%

Russell 1000

4,129.01

−49.82

-1.19%

S&P MidCap 400

3,662.50

−96.39

-2.56%

Russell 2000

2,870.29

−89.91

-3.04%

Russell 2500

1,229.06

−8.46

-0.68%

Russell 3000

4,305.12

−55.30

-1.27%

Nasdaq Financial-100

7,536.29

−124.39

-1.62%

NIFTY 50

23,118.60

−312.90

-1.34%

VIX

17.20

+0.74

+4.50%

Biggest Gainers

Tue, Sep 15, 2026 50

ROC

ROC Energy Acquisition Corp.

$4.26+$1.75

+69.7%

NASDAQ · Mkt cap $83 M

No news headlines were found in the last 48 hours, so the 69.72% gain cannot be attributed to any identified public announcement or disclosure. The jump may reflect technical trading, merger speculation, or delayed market reaction to an earlier event.

The absence of recent news headlines creates significant uncertainty about the cause of ROC Energy Acquisition Corp.'s dramatic rally. ROC is a blank-check company, meaning it is a SPAC that trades on its cash and the market's expectation of a future merger or business combination. For this type of security, large single-day moves can occur without corresponding news coverage if: (1) a merger target is named or expected imminently, triggering speculative buying before official announcement; (2) technical factors or short covering drive the move; (3) news exists but has not yet been indexed by the RSS feed used here; or (4) retail or institutional positioning changes rapidly in anticipation of an event. Without headline confirmation, none of these explanations can be ranked as more likely than the others. The magnitude of the move (69.72%) suggests something material occurred or is expected, but the mechanism remains opaque.

PDSB

PDS Biotechnology CorpHealthcare

$0.58+$0.21

+47.9%

NASDAQ · Mkt cap $11 M

PDS Biotech announced a $22.3 million PIPE financing led by billionaire Dr. Patrick Soon-Shiong and his appointment to the board, triggering a 48% rally on investor confidence in the backing and leadership.

The stock jumped nearly 48% following two linked announcements on September 14: completion of the initial close of a PIPE (private investment in public equity) worth up to $22.3 million led by Nant Capital, and the appointment of Dr. Patrick Soon-Shiong to PDS Biotech's board. Soon-Shiong is a prominent billionaire investor and founder of NantWorks with a track record in life sciences and biotechnology. For a small-cap biotech trading at $0.58, this type of high-profile institutional backing and board representation signals both capital stability and credibility. The PIPE provides immediate liquidity, while Soon-Shiong's involvement—particularly his simultaneous backing of at least one other immunotherapy platform (IBRX)—suggests confidence in the company's cancer-immunotherapy platform. This combination of capital infusion and executive credibility is a classic catalyst for micro-cap biotech rallies.

WAFU

Wah Fu Education Group LtdConsumer Defensive

$1.37+$0.55

+41.4%

NASDAQ · Mkt cap $6.3 M

Wah Fu Education surged 41% following announcement that its AI Ecosystem Intelligent Agent Industrialization Project passed review for Hangzhou's local innovation-and-entrepreneurship program, signaling validation of its AI strategy and potential commercialization pathway.

The headline establishes that Wah Fu Education received official approval from Hangzhou authorities for an AI-related project on the same day as the 41% jump. This represents a tangible milestone in the company's artificial intelligence initiative rather than speculative news. The announcement framing emphasizes "industrialization" and successful project review, which investors may interpret as progress toward revenue-generating AI products or services. For a small-cap education company, regulatory validation of an emerging technology initiative can carry outsized significance given growth expectations and the current market enthusiasm for AI-adjacent businesses. The timing of the announcement and the magnitude of the price move align logically, though without visibility into trading volume, short interest, or broader market context on this specific stock, we cannot rule out technical factors amplifying the move.

TPST

Tempest Therapeutics Inc.

$0.75+$0.31

+39.0%

VRA

Vera Bradley Inc

$4.09+$1.16

+38.2%

VEEA

Veea Inc.Technology

$5.70+$1.58

+37.6%

NASDAQ · Mkt cap $8.6 M

Veea announced a merger with NovaGen to form an Edge AI-powered health platform with Nasdaq listing and $10M cornerstone investment backing, driving the 37.62% gain.

The headline explicitly describes a merger announcement between Veea Inc. and NovaGen, which is a material corporate event that directly justifies a significant stock price jump. The proposed combination creates a Nasdaq-listed platform combining edge AI infrastructure (Veea's core business) with longevity and precision-health capabilities. The announcement includes concrete backing from GeoNova Capital committing $10 million as a cornerstone investor, which provides financial credibility to the deal. Merger announcements, especially those involving strategic complementary businesses and institutional backing, routinely drive same-day or next-day stock appreciation, as investors view the combined entity as having enhanced market positioning and growth prospects. The timing aligns perfectly with the price move observed on September 15th, one day after the announcement on September 14th.

YFOR

YYForce Inc. Class A

$1.43+$0.49

+35.4%

PSIG

PS International Group Ltd. Ordinary SharesIndustrials

$3.39+$0.88

+34.8%

NASDAQ · Mkt cap $31 M

No news headlines were available in the last 48 hours to explain PSIG's 34.79% surge, leaving the exact catalyst unclear; a delayed announcement, technical rebound, or rumor could have driven the jump.

Despite ranking as the eighth biggest gainer on September 15, 2026, no recent news appeared in the Yahoo Finance RSS feed for PSIG in the preceding 48 hours. This absence of reported headlines makes it impossible to attribute the move to a specific corporate event like earnings, guidance, a contract win, or strategic announcement. The magnitude of the gain (nearly 35%) suggests something material reached the market, but without evidence of what that was, the cause remains speculative. Possibilities include a delayed press release not yet indexed by RSS feeds, a technical reversal after a prior decline, analyst commentary, insider activity, or retail momentum on social media. Lower-cap stocks like PSIG are sometimes more prone to sentiment-driven moves on limited news flow.

BNGO

BioNano Genomics IncHealthcare

$1.54+$0.44

+32.8%

NASDAQ · Mkt cap $14 M

BioNano announced three new peer-reviewed studies demonstrating clinical value of its optical genome mapping technology across blood cancers, likely driving a 32.84% single-day gain as positive clinical validation.

The headline documents that independent research teams at three respected institutions (MD Anderson Cancer Center, University of Oulu, Josep Carreras Leukaemia Research Institute) published findings showing BioNano's optical genome mapping (OGM) uncovers clinically significant genomic alterations in myelodysplastic syndromes and acute myeloid leukemia. For a clinical diagnostics or genomics company with a market cap indicating retail investor presence, third-party validation from major cancer research centers carries material weight—it reduces perceived execution risk and broadens addressable indications. The timing of the announcement on September 14 aligns directly with the September 15 price jump, suggesting market participants viewed multiple peer-reviewed publications as meaningful de-risking of the technology's clinical applicability. This is a classic catalyst for small-cap biotech stocks where clinical adoption uncertainty is priced in.

dMY Squared Technology Group, Inc.Technology

$13.23+$2.88

+27.8%

NASDAQ · Mkt cap $905 M

Horizon Quantum Holdings announced a clarification regarding certain company information on September 15, 2026, coinciding with a 27.76% intraday surge, though the specific details of the clarification are not disclosed in the headline.

The news headline indicates that Horizon Quantum Holdings (trading as HQ) issued a statement to clarify certain information about the company on the day of the stock's 27.76% jump. However, the actual content of that clarification is not provided—the headline is truncated mid-sentence. Without knowing what was clarified (whether it concerns financial results, business operations, regulatory status, partnership announcements, or resolution of prior uncertainty), we cannot directly link the news to the move. Given that this is a quantum computing software infrastructure company, typical catalysts for such gains would include partnership announcements, product milestones, or resolution of previous concerns. The timing between the news release and the intraday surge suggests correlation, but the missing details prevent confirmation of causation.

FBDT

First Breach Inc.

$0.99+$0.17

+25.7%

CLNN

Clene Inc.Consumer Defensive

$4.02+$0.74

+22.6%

NASDAQ · Mkt cap $54 M

Clene announced a $4 million registered direct offering led by its Chairman and supported by existing major shareholders, which likely signaled confidence in the company and provided near-term capital, triggering a 22.56% gain.

The registered direct offering announcement came with notable endorsements from insiders and existing investors, including the Chairman of the Board, CEO, and founding investor Kensington Capital Holdings. This pattern of insider participation in a capital raise is often interpreted positively by markets as a vote of confidence in the company's direction and valuation. The fact that multiple existing stakeholders chose to invest alongside the offering rather than allowing dilution to fall entirely on current shareholders can reduce negative sentiment around equity raises, which typically weigh on stock prices. For a micro-cap biotech or development-stage company like Clene, securing $4 million in committed capital with insider backing addresses near-term funding uncertainty, which is often a primary risk factor. The timing of the announcement coinciding with the trading day's strong performance suggests the market viewed this as constructive news for near-term runway and strategic positioning.

GVH

Globavend Holdings LimitedIndustrials

$1.28+$0.23

+21.9%

NASDAQ · Mkt cap $2.4 M

No headlines were available in the last 48 hours for GVH, so the 21.90% gain cannot be directly attributed to a documented news event; the jump may reflect technical factors, delayed news, or retail trading activity.

The absence of any headlines in the RSS feed over the past two days makes it impossible to link the strong 21.90% gain to a specific catalyst such as earnings, product announcements, regulatory approvals, or strategic partnerships. For a microcap stock like GVH trading at $1.28, price moves of this magnitude often occur in response to short covering, technical breakouts above resistance levels, social media attention, or accumulation by retail traders. It is also possible that relevant news was published but did not appear in the Yahoo Finance RSS feed within the time window captured, or that the catalyst was an intraday or after-hours development. Without either headline evidence or known structural characteristics of the stock that would explain outsized volatility, the move remains unexplained by the available data.

HLP

Hongli Group Inc. - Ordinary SharesBasic Materials

$1.80+$0.31

+20.8%

NASDAQ · Mkt cap $90 M

No news headlines are available in the last 48 hours to explain the 20.81% gain in HLP stock, so the driver remains unclear without additional context.

The absence of recent news headlines makes it impossible to identify a specific catalyst for HLP's strong 20.81% move up to $1.80. For a stock trading at this price level, potential drivers could include technical factors such as short covering or a breakout from consolidation, small-cap momentum plays responding to broader market sentiment, rumors or social media activity not yet captured in major news feeds, or a delayed market reaction to an older announcement. Without verifiable information about company-specific events like earnings results, financing news, operational updates, or analyst activity, any explanation would be speculative. Investors should check the company's investor relations page or SEC filings for any recent announcements that may not have been picked up by major financial news aggregators.

Skycorp Solar Group Limited Ordinary SharesEnergy

$2.41+$0.41

+20.5%

NASDAQ · Mkt cap $5.4 M

No news headlines were found in the last 48 hours, so the 20.5% gain in PN (Skycorp Solar Group) cannot be directly attributed to a reported event; this type of move typically reflects sector momentum, technical trading, or untracked news flow.

The absence of any news headlines in the Yahoo Finance RSS feed over the past two days leaves the catalyst for PN's strong 20.5% intraday gain unexplained by public announcements. For a solar energy company, plausible drivers of this magnitude could include sector-wide positive sentiment (e.g., renewable energy legislation or commodity price movements), short-squeeze activity given the stock's lower price point, technical breakouts above resistance levels, or earnings or guidance news that has not yet been picked up by mainstream financial news sources. The stock ranking as the 15th biggest gainer suggests broad market participation rather than a single stock-specific catalyst, which may point toward sector rotation or macro factors affecting renewable energy equities more broadly.

UPLD

Upland Software IncTechnology

$3.76+$0.63

+20.1%

NASDAQ · Mkt cap $13 M

No news was available in the last 48 hours to explain UPLD's 20% jump, so the catalyst remains unclear; the move likely reflects either delayed news dissemination, technical trading, or a corporate announcement not yet indexed by Yahoo Finance.

The absence of any headlines in the 48-hour window prior to the +20.13% rally is notable and limits our ability to pinpoint a cause. For a software company like Upland, typical catalysts would include earnings surprises, new customer wins or contract announcements, guidance raises, strategic partnerships, acquisition news, or insider buying signals. The stock ranked 16th among daily gainers, suggesting broad market awareness of something, yet no corresponding news appears in the feed provided. This gap could indicate either that a material announcement was released but not yet reflected in the Yahoo Finance RSS feed at the snapshot date, that news broke very early in the trading window before traditional media pickup, or that the move reflects technical factors such as short covering or options-driven positioning rather than a fundamental catalyst.

FLYX.WT

flyExclusive, Inc.

$0.13+$0.02

+19.0%

NTRP

Neurotrope IncConsumer Cyclical

$1.80+$0.29

+18.9%

NASDAQ · Mkt cap $22 M

A headline about NextTrip's JOURNY TV premiere of "I DO: In Destination" was published today, but the news appears unrelated to Neurotrope Inc (ticker NTRP). The 18.87% gain likely reflects either a ticker confusion, a delayed market reaction to other catalysts, or technical trading activity.

The provided headline concerns NextTrip's streaming content strategy and a travel-themed television series premiere, which has no clear connection to Neurotrope Inc, a company whose name suggests neuroscience or pharmaceutical focus. This mismatch raises the possibility of a data error, delayed market reaction to undisclosed catalyst, or confusion between similarly-named securities. For a small-cap NASDAQ stock up nearly 19%, typical catalysts include clinical trial results, partnership announcements, insider activity, or retail-driven momentum plays. Without a substantive news event clearly tied to Neurotrope's business operations in the headlines provided, the root cause remains unclear.

IPEX

Inflection Point Acquisition Corp.

$10.40+$1.61

+18.4%

BGMS

Cyclacel Pharmaceuticals, Inc.Healthcare

$1.05+$0.16

+18.3%

ERNA

Eterna Therapeutics Inc.Healthcare

$4.09+$0.77

+18.2%

NASDAQ · Mkt cap $5.2 M

Ernexa (ticker ERNA) reported positive preclinical data for ERNA-201 showing disease-modifying activity in arthritis models, expanding the pipeline beyond oncology and supporting acceleration toward first-in-human dosing, likely driving the 18% gain.

The 18.2% jump on September 15 aligns directly with the release of positive preclinical data for ERNA-201 in a collagen-induced arthritis model, demonstrating that Ernexa's engineered synthetic induced mesenchymal stem cell (iMSC) platform shows efficacy beyond its initial oncology focus. This de-risks the broader platform and provides proof-of-concept in a different therapeutic area. The timing also coincides with the company's presentation scheduled for the H.C. Wainwright conference on September 16, which may have amplified investor interest ahead of that event. For a preclinical-stage biotech, positive data announcements and platform validation typically drive meaningful single-day moves, especially when they expand the addressable market or reduce perceived execution risk.

KBSX

FST Corp. Ordinary SharesConsumer Cyclical

$1.18+$0.18

+18.0%

NASDAQ · Mkt cap $45 M

No news headlines were found in the last 48 hours for KBSX, so the 18% gain on September 15 likely reflects either a delayed market reaction to an earlier announcement, technical trading, or a catalyst not yet picked up by major news feeds.

The absence of recent headlines despite a substantial single-day gain of 18% (placing KBSX at rank 22 among gainers) suggests the move was not triggered by a breaking news event reported in the last 48 hours. This pattern can occur when markets react to older announcements, regulatory filings, or analyst upgrades that take time to propagate. For a lower-priced NASDAQ stock like FST Corp. trading at $1.18, the most common catalysts include clinical trial results or regulatory approvals (if biotech), partnership announcements, insider buying, short-squeeze activity, or broad sector rotation. Without access to the specific business of FST Corp. or earlier news archives, the most likely hypothesis is either a delayed reaction to a prior announcement or technical momentum in a low-float name, but this remains inference rather than confirmation.

SKIL

Skillsoft Corp.Consumer Defensive

$5.83+$0.87

+17.5%

NYSE · Mkt cap $71 M

No news headlines were found in the last 48 hours to explain the 17.54% gain, so the driver remains unclear without additional context or intraday reporting.

Skillsoft Corp. jumped 17.54% with no apparent news catalyst in the available headlines from the last 48 hours. For a corporate training and compliance software vendor like SKIL, typical upside drivers include earnings beats, new major contract wins, analyst upgrades, dividend announcements, or strategic guidance raises. Without news confirmation, the move could reflect delayed coverage of an earlier announcement, technical momentum or short covering, market-wide sector rotation into software or education technology, rumors not yet published widely, or an earnings report that posted outside the news feed window. A direct company announcement or earnings release would be the most likely candidate; alternatively, institutional buying pressure or retail interest could drive intraday gains without immediate news justification.

ETS

ELITE EXPRESS HOLDING INCIndustrials

$1.88+$0.28

+17.5%

NASDAQ · Mkt cap $54 M

No news headlines were found in the last 48 hours for ETS, so the 17.5% gain lacks an obvious publicly reported catalyst. The move may reflect technical trading, delayed news dissemination, or other undisclosed market factors.

The absence of recent news headlines makes it difficult to attribute the 17.5% jump to a specific fundamental event. Elite Express Holding is a small-cap stock trading near $1.88, which can experience outsized intraday volatility from modest volume or technical triggers. Possible explanations include a delayed earnings report or regulatory filing not yet indexed by Yahoo Finance, a short squeeze or technical breakout on the daily chart, sector rotation into logistics or transportation plays, or pre-announcement buying ahead of after-hours news. Without corroborating headlines or structural data about the company's float and short interest, we cannot definitively isolate the cause.

REED

Reed's IncConsumer Defensive

$0.83+$0.11

+16.0%

NYSE · Mkt cap $13 M

No news headlines were found in the last 48 hours for Reed's Inc, so the 16% gain on September 15 likely stems from technical trading, delayed press releases, or sector-wide sentiment rather than a identifiable company-specific catalyst.

Reed's Inc experienced a significant single-day jump of 16.02% to $0.83 per share, ranking it among the top 25 gainers for the day. However, no news headlines appeared in the Yahoo Finance RSS feed for the preceding 48 hours. This disconnect suggests several possible explanations. First, the stock trades at a very low price point, making it susceptible to momentum-driven retail trading or technical bounces. Second, a press release or announcement may have been issued but not yet indexed by major news aggregators. Third, sector-wide tailwinds in beverage or consumer packaged goods stocks could have lifted REED along with peers. Fourth, short covering or options expiration dynamics could drive a low-priced stock higher without fundamental catalyst. Without corresponding headline evidence, attribution remains speculative and the move may reflect technical factors or delayed information propagation rather than new company-specific developments.

BCHT

Birchtech Corp.Industrials

$1.61+$0.22

+15.9%

NYSE · Mkt cap $34 M

No headlines were found in the last 48 hours, so the 15.94% gain cannot be directly attributed to a specific news catalyst. The move likely stems from technical trading, short covering, or an unindexed event.

The absence of any recent news headlines makes it impossible to tie BCHT's significant one-day gain to a concrete catalyst such as earnings, product announcements, or strategic moves. A micro-cap stock trading at $1.61 is vulnerable to several non-news drivers: retail momentum or social media attention, short squeeze dynamics if the stock has high short interest, technical breakouts above key resistance levels, or delayed market reaction to older announcements not yet indexed by the RSS feed. Birchtech appears to be a low-priced equity with limited float, which amplifies price swings on modest volume. Without access to intraday volume data, short interest trends, or verified material developments, the underlying catalyst remains opaque.

DRCT

Direct Digital Holdings, Inc.Communication Services

$2.09+$0.28

+15.6%

NASDAQ · Mkt cap $2.0 M

No news headlines were found in the last 48 hours for DRCT, so the 15.6% gain likely reflects technical buying, delayed reaction to an earlier announcement, or market rumors not yet captured in major news feeds.

Direct Digital Holdings experienced a significant single-day jump of 15.6% to rank as the 27th biggest gainer on NASDAQ, yet no corresponding news headlines appear in the available RSS feed from the past two days. This disconnect suggests several possibilities worth considering. The move could be driven by technical factors such as short covering, algorithmic buying following a break through a resistance level, or accumulation by institutions ahead of an anticipated event. Alternatively, the catalyst may have been disseminated through channels not captured by the Yahoo Finance headlines checked here, such as a press release issued after market close, an earnings report, a contract win, or management commentary at a conference. For a smaller-cap digital marketing company like DRCT, such moves sometimes reflect insider confidence, analyst upgrades, or sector tailwinds in advertising technology. Without corroborating headline evidence, however, these remain informed guesses rather than confirmed causes.

VWAV

VisionWave Holdings, Inc.Industrials

$0.53+$0.07

+15.1%

NASDAQ · Mkt cap $36 M

VisionWave filed a non-provisional patent for ARGUS, a space-based AI counter-drone defense system, on September 14, likely triggering the 15% intraday gain as investors reacted to the intellectual property filing and potential defense market opportunity.

The patent filing announcement on September 14 describes a comprehensive architecture combining space-based sensing, artificial intelligence, communications, and multi-effector drone defense capabilities. For a micro-cap stock trading at $0.53, a patent filing in an emerging defense technology space can generate significant speculative interest, especially if the market perceives it as validating the company's technical roadmap or competitive positioning in counter-UAS systems. The timing between the announcement and the price jump suggests direct causation. However, the headline excerpt is truncated and does not provide details on the patent's strength, commercial timeline, funding status, or partnership announcements, which would normally drive institutional buying rather than retail momentum.

BBNX

Beta Bionics, Inc. Common Stock

$19.26+$2.50

+14.9%

PHOE

PHOENIX ASIA HOLDINGS LIMITEDIndustrials

$22.00+$2.90

+14.7%

NASDAQ · Mkt cap $526 M

No news headlines were found in the last 48 hours, so the 14.65% gain cannot be attributed to a publicly reported catalyst; the move likely reflects technical trading, delayed news pickup, or undisclosed developments.

Yahoo Finance's RSS feed returned no headlines for PHOENIX ASIA HOLDINGS LIMITED in the 48 hours preceding this snapshot. This absence of reported news makes it impossible to identify a specific fundamental catalyst such as earnings, guidance, partnerships, or regulatory approvals. A 14.65% single-day jump for a stock ranked 30th among daily gainers is substantial and typically signals either material company news (not yet widely reported), short-covering, technical breakout above a key level, sector rotation, or speculative buying. Without access to alternative news sources, earnings calendars, or trading flow data, we cannot distinguish between these possibilities. The stock trades on NASDAQ, so it is subject to standard disclosure rules, yet the headline gap suggests either a lag in news aggregation or that trading volume and interest may be outpacing formal announcements.

INDP

Indaptus Therapeutics, Inc.Healthcare

$3.61+$0.45

+14.2%

NASDAQ · Mkt cap $125 M

No news headlines were found in the last 48 hours, so the 14.24% gain on INDP likely stems from technical factors, a delayed announcement, or market rumor not yet indexed in major feeds.

The absence of any recent headlines in the Yahoo Finance RSS feed for Indaptus Therapeutics makes it difficult to pinpoint a specific catalyst for the 14.24% single-day jump. For a small-cap biotech like INDP, price movements of this magnitude are typically driven by clinical trial results, FDA decisions, partnership announcements, or shifts in investor sentiment tied to pipeline progress. It is also possible that news broke through a non-indexed channel, a delayed market reaction to an older announcement, or technical momentum from short covering or low-volume trading activity. Without corroborating headlines or press releases, we cannot identify the precise cause.

ZDAI

Primega Group Holdings LimitedIndustrials

$1.65+$0.20

+14.0%

NASDAQ · Mkt cap $13 M

No news was published about ZDAI in the last 48 hours, so the 13.99% gain on September 15 likely reflects a delayed reaction to an earlier announcement, technical buying, or market speculation unconfirmed by available headlines.

The absence of any Yahoo Finance headlines in the past 48 hours means no major corporate event or market-moving announcement can be directly tied to today's sharp 13.99% gain. ZDAI is a penny stock trading at $1.65, which makes it susceptible to several common drivers of outsized daily moves: delayed reactions to older news that failed to register immediately, short-covering rallies if the stock carries a high short interest, technical or algorithmic buying triggered by chart patterns or volume thresholds, or speculative accumulation based on rumors not yet picked up by major news outlets. Without access to prior news, insider transactions, or borrow-fee data, determining which mechanism is at work here is not possible from the evidence at hand.

IPW

iPower Inc.Consumer Cyclical

$2.61+$0.26

+13.8%

NASDAQ · Mkt cap $5.9 M

No news headlines were found in the last 48 hours to explain IPW's 13.76% gain, so the driver remains unclear; the move may reflect technical trading, delayed news dissemination, or sector rotation in small-cap growth stocks.

The absence of recent news headlines is notable given the magnitude of the single-day move. iPower Inc. is a small-cap NASDAQ-listed company in the hydroponics and horticultural equipment space, which can experience outsized daily volatility on relatively light volume. Without identified fundamental catalysts from the news feed, several inference categories are plausible: the stock may have benefited from short covering or algorithmic momentum buying, sector-wide interest in cannabis-adjacent or agricultural-tech stocks, or delayed market reaction to older news not captured in the 48-hour window. Penny and micro-cap stocks often respond to technical levels, insider accumulation signals, or social media attention. The 33 ranking as a top gainer suggests broad market participation, which could indicate a technical breakout rather than company-specific news.

QXL

Quantum X Labs Inc.Technology

$4.83+$0.59

+13.7%

NASDAQ · Mkt cap $59 M

Quantum X Labs announced the appointment of Yossi Cohen, former Mossad Director and SoftBank strategic advisor, as President of its Scientific Advisory Board, likely driving the 13.72% gain through perceived credibility and high-profile backing.

The single headline provided announces a significant executive appointment rather than a financial milestone, earnings release, or product breakthrough. Yossi Cohen's credentials—former head of Israel's intelligence agency and current strategic advisor to SoftBank, a major global technology investor—appear designed to signal organizational legitimacy and potential access to capital or strategic partnerships. For a small-cap quantum technology company trading at $4.83, such a high-profile advisory board appointment can shift investor sentiment substantially, especially if it suggests validation from an established tech investment ecosystem. However, the headline does not disclose financial terms, timeline to commercialization, partnerships, or any binding commitments, so the market's interpretation is based primarily on reputation signaling rather than concrete business developments.

HEPA

Hepion Pharmaceuticals IncHealthcare

$0.06+$0.01

+13.6%

NASDAQ · Mkt cap $5.5 M

No news headlines were found in the last 48 hours, so the 13.64% gain likely stems from technical trading, a delayed announcement, or retail interest in this low-priced biotech stock.

Hepion Pharmaceuticals is a micro-cap biotech trading at $0.06 per share with no recent news coverage available. The absence of any headlines in the 48-hour window before this 13.64% jump makes it impossible to attribute the move to a specific company catalyst like clinical trial results, regulatory action, or partnership news. For stocks at this price point and market cap, moves can be driven by several factors: technical oversold conditions triggering algorithmic or retail buying, delayed announcements not yet captured in the news feed, options expiration activity, or broader sector rotation in penny biotech. Without visibility into the actual trigger, the most honest assessment is that this appears to be either noise-driven trading or a catalyst that simply hasn't appeared in the provided news sources yet.

SWKS

Skyworks Solutions IncTechnology

$90.00+$10.77

+13.6%

NASDAQ · Mkt cap $11 B

Skyworks rallied 13.59% on renewed optimism around Apple smartphone component demand and progress on its pending Qorvo merger, reversing a prior AI-related selloff that had briefly weakened the stock on Monday.

The headlines establish that Skyworks experienced a sharp recovery on September 15 after a Monday decline tied to broad AI sector weakness. Multiple sources cite two concrete catalysts: expectations for stronger component sales from Apple's latest smartphone launch, and progress on the company's merger with Qorvo, which had previously faced uncertainty. The stock had already surged well above analyst price targets before this date, suggesting latent bullish positioning. One article notes the rally occurred while large-cap tech broadly declined and Treasury yields climbed, indicating this was a rotation into semiconductor suppliers rather than a broad market lift. The prior selloff on September 14 was tied to public statements from AI company leaders calling for development slowdowns, which temporarily hurt tech stocks but appears to have had minimal lasting impact on SWKS specifically. The dividend cut and debt increase mentioned in one headline suggest management is prioritizing growth and acquisition financing, which may be supporting investor appetite for the turnaround narrative.

IMTE

Integrated Media Technology LtdTechnology

$0.52+$0.06

+13.5%

NASDAQ · Mkt cap $1.7 M

No news headlines were available in the past 48 hours, so the 13.5% gain likely reflects technical trading activity, short covering, or an untracked announcement or rumor in this micro-cap stock.

IMTE saw a substantial intraday gain with no corresponding news coverage in the Yahoo Finance RSS feed over the last two days. For a micro-cap stock trading at $0.52, price moves of this magnitude are common even without material catalysts and can result from several factors: thin liquidity making small volume surges produce large percentage swings, technical bounce-back after a prior decline, retail or algorithmic trading momentum, short-squeeze activity if the float is tight, or an announcement made through channels not captured in the RSS feed. Without access to company filings, press releases, or broader financial media, it is not possible to confirm whether a specific event drove the move or whether it was purely technical in nature.

JONER

Jones Ventures INTL Acquisition1 Corp

$0.17+$0.02

+13.3%

FTRE

Fortrea Holdings Inc. - Common StockHealthcare

$19.73+$2.31

+13.3%

FCHL

Fitness Champs Holdings LimitedConsumer Defensive

$1.13+$0.13

+13.2%

NASDAQ · Mkt cap $1.5 M

No news headlines were found in the last 48 hours for FCHL, so the 13.16% gain likely stems from technical trading, retail interest, or an announcement not yet picked up by major financial news feeds.

The absence of recent news headlines makes it impossible to identify a specific fundamental catalyst for the 13.16% intraday gain. FCHL is a micro-cap fitness company stock, which as a category tends to exhibit high volatility and can be sensitive to social media mentions, short-squeeze dynamics, or delayed news coverage. Possible explanations include a positive earnings announcement or business development news released outside the 48-hour window tracked here, accumulation by retail traders, technical momentum from breaking a resistance level, or coverage by lesser-known financial channels not reflected in the Yahoo Finance RSS feed provided. Without access to company filings, press releases, or broader market data for the same period, attributing the move to any specific event would be speculation.

TOPS

TOP Ships IncEnergy

$0.80+$0.09

+13.1%

NYSE · Mkt cap $4.9 M

No news headlines were found in the last 48 hours to explain the 13.08% gain in TOPS. The move likely reflects technical factors, sector sentiment, or untracked developments specific to this shipping company.

TOP Ships Inc experienced a substantial single-day jump with no corresponding earnings announcement, contract award, regulatory action, or other identifiable fundamental news in the available headlines. For a small-cap maritime logistics stock, price moves of this magnitude in the absence of disclosed news typically occur due to one or more of several factors: technical momentum or chart-driven buying, positive sector rotation within shipping equities, short covering if the stock has significant short interest, delayed news or press releases not yet indexed in major feeds, or retail social media-driven trading activity. The stock's low absolute price of $0.80 also makes it susceptible to larger percentage swings on modest volume changes. Without access to company filings, news wires, or sector catalysts released in the prior 48 hours, we cannot pinpoint the specific driver.

WNW

Wunong Net Technology Company Limited

$2.38+$0.30

+12.6%

ELOX

Eloxx Pharmaceuticals IncHealthcare

$18.28+$2.02

+12.4%

NASDAQ · Mkt cap $62 M

No news headlines were found in the last 48 hours, so the 12.42% gain cannot be directly attributed to a disclosed catalyst. The move may reflect technical trading, market sentiment shifts, or undisclosed material developments in a small-cap biotech stock.

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on rare genetic diseases. The absence of recent news headlines makes it difficult to pinpoint the driver of today's 12.42% move. Biotech stocks of this size and stage are often volatile and can respond sharply to technical factors, short covering, or sentiment swings unrelated to public announcements. Possible catalysts include clinical trial updates, partnership discussions, or investor positioning changes that may not have been immediately captured in the Yahoo Finance RSS feed. Without disclosed news, attributing the move to fundamentals is speculative.

KRSP.WT

$1.00+$0.11

+12.4%

SDGR

Schrodinger Inc-United StatesHealthcare

$23.26+$2.50

+12.0%

NASDAQ · Mkt cap $1.5 B

No news headlines were found in the last 48 hours for Schrodinger Inc, so the 12% gain on September 15 cannot be directly attributed to a disclosed corporate event. The move likely reflects either a delayed market reaction to earlier news, technical trading, or an untracked catalyst.

Schrodinger is a computational drug discovery platform company, and stock movements of this magnitude typically correlate with clinical trial outcomes, partnership announcements, or changes in guidance from management. Without recent headlines, we cannot identify a specific news catalyst for the 12.04% gain. This could represent a delayed market reaction to news released before the 48-hour window, short-covering on a stock with elevated short interest, momentum-driven technical buying, or an untracked announcement such as a partnership with a major pharmaceutical firm or positive preclinical data not yet widely covered by major financial news outlets. Biotech and software-as-a-service stocks in the drug discovery space are also sensitive to broader sector sentiment shifts, FDA policy changes, or analyst upgrades that may not appear immediately in Yahoo Finance headlines.

ARQQ

Arqit Quantum Inc.Technology

$18.23+$1.91

+11.7%

NASDAQ · Mkt cap $375 M

No news headlines were found in the last 48 hours for ARQIT Quantum, so the 11.69% gain likely reflects either delayed market reaction to a prior announcement, technical trading activity, or sector-wide momentum in quantum computing stocks.

The absence of recent news headlines makes it impossible to tie this substantial single-day gain to a specific corporate event like earnings, partnerships, product launches, or guidance changes. ARQIT is a quantum computing company, a sector that can experience significant volatility based on investor sentiment, fund rebalancing, or broad technology momentum shifts. The stock ranks 46th among daily gainers despite no identifiable catalyst in the available news feed, suggesting either: one, a material announcement was made but has not yet appeared in the 48-hour RSS feed; two, algorithmic or retail trading activity concentrated on the name; or three, positive sentiment from related sector news (quantum industry developments, cryptography regulation, or defense spending) that indirectly benefited the stock without direct attribution.

ORKT

Orangekloud Technology Inc. Class A Ordinary Shares

$1.08+$0.11

+11.3%

FGI

FGI Industries Ltd.Consumer Cyclical

$9.95+$1.01

+11.2%

NASDAQ · Mkt cap $18 M

No headlines were found in the last 48 hours to explain FGI's 11.24% gain, so the catalyst remains unknown; the move could reflect delayed news dissemination, technical trading, or an untracked announcement.

The absence of any Yahoo Finance headlines in the last 48 hours makes it impossible to identify a specific catalyst for FGI's significant 11.24% jump. This gap between price action and news coverage could occur for several reasons. First, the news might exist but not yet be indexed by the RSS feed used here. Second, the move could be driven by technical factors such as short covering, options expiration effects, or algorithmic trading. Third, FGI could have announced earnings, guidance, a contract, or corporate action that hasn't yet propagated through major financial news aggregators. Without access to the company's investor relations site, SEC filings, or real-time alerts, we cannot determine whether this is a fundamental repricing or purely technical momentum.

RKTO

Rocket One Inc.

$0.76+$0.08

+11.1%

NVNI

Nvni Group Limited - Ordinary SharesTechnology

$0.99+$0.10

+11.0%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours, so the 10.95% jump on NVNI is unexplained by published reporting. The move likely reflects either technical trading, delayed news dissemination, or market rumors.

NVNI traded at $0.99 on September 15, 2026, marking a notable 10.95% daily gain and ranking it among the day's top 50 gainers. However, no news headlines were published in the prior 48 hours to account for this move. In the absence of reported catalysts, penny stocks and micro-cap securities like NVNI often respond to retail momentum, short-covering, or unvetted rumors circulating on retail trading platforms. A stock at this price point and exchange tier may also be subject to low liquidity, meaning even modest share purchases can produce outsized percentage moves. Without access to social media chatter, regulatory filings, or press releases issued directly by the company, it is not possible to identify a specific trigger.

Biggest Losers

Tue, Sep 15, 2026 50

HCMA

HCM Acquisition CorpFinancial Services

$0.21−$10.11

-98.0%

NASDAQ · Mkt cap $347 M

No news headlines are available in the last 48 hours to explain the 98% crash in HCMA stock, making the specific catalyst unknown, though a SPAC merger failure, regulatory setback, or going-concern issue are typical drivers of such severe declines.

HCM Acquisition Corp (HCMA) experienced a catastrophic 98% single-day loss with no corresponding news coverage in the most recent 48-hour period. This absence of headlines is itself significant and suggests either a delayed reporting lag or a development that markets priced in before traditional news outlets published. HCMA is a SPAC (Special Purpose Acquisition Company), and the stock's extreme collapse points to common failure modes in that category: a merger deal may have collapsed, regulatory or shareholder approval could have been denied, or the company may have disclosed material adverse developments (liquidity crisis, going concern warning, management departures). The pricing at $0.21 suggests near-total equity value destruction. Without direct news evidence, attributing the move to a specific event requires inference based on typical SPAC failure patterns rather than confirmed fact.

FEED

ENvue Medical, Inc.Healthcare

$1.02−$2.68

-77.2%

NASDAQ · Mkt cap $3.9 M

ENvue Medical announced a Nasdaq listing update on September 15, which likely triggered the 77% collapse, suggesting delisting risk or a severe corporate action that destroyed shareholder value.

The only headline provided is an extremely vague "Nasdaq Listing Update" from ENvue Medical released on the same day as the catastrophic 77% drop. The press release text is truncated and does not disclose what the update actually contains. A -77% single-day move on a micro-cap stock is consistent with delisting notification, reverse split announcement, significant dilution, or other existential corporate events. Without the full text of the announcement, we cannot identify the specific catalyst. The fact that the company issued a press release concurrent with the collapse suggests the update itself triggered the selling, rather than external news or market conditions. Small-cap and penny stocks are particularly vulnerable to binary corporate events that can wipe out significant value in minutes.

NAOV

NanoVibronix Inc

$1.03−$2.32

-69.3%

HCAI

Hauchen AI Parking Management Technology Holding Co., Ltd. Ordinary SharesIndustrials

$0.61−$1.30

-68.1%

NASDAQ · Mkt cap $7.9 M

Huachen AI announced a $2.75 million registered direct offering on September 15, which typically causes immediate dilution-driven selling and a sharp stock decline as new shares are priced at a discount to market value.

The company announced pricing of a registered direct offering for $2.75 million on the same day as the massive 68% drop. Registered direct offerings involve the immediate issuance of new shares at a negotiated price, almost always below the current market price, creating immediate shareholder dilution. The timing of the announcement with the stock's position as the fourth-biggest loser suggests the market reacted negatively to the dilutive capital raise. The headline is truncated and does not specify the offering price per share, but the magnitude of the decline is consistent with how the market typically responds when a micro-cap or penny stock announces equity offerings. Without more details on shares outstanding, offering price, or company guidance, the precise calculation of dilution impact cannot be determined, but equity raises of this type are commonly a primary driver of sharp declines in small-cap stocks.

CTNT

Cheetah Net Supply Chain Service Inc. - Class A Common StockIndustrials

$0.06−$0.09

-59.0%

NASDAQ · Mkt cap $5.0 M

Cheetah Net announced a $788,000 acquisition of JoyPak Supply to diversify into consumer and beauty products, but the 59% single-day collapse suggests severe investor concerns about valuation, capital allocation, or undisclosed financial distress rather than enthusiasm for the deal itself.

The news headlines on September 15 document Cheetah Net's entry into a deal to acquire JoyPak Supply, framed as a diversification move into consumer and beauty products. However, a 59% single-day drop on an acquisition announcement of this modest size is unusual and typically signals that the market views the move negatively. Possible explanations include concern that the company is deploying capital poorly given its current market capitalization (implied to be under $50 million given the stock price), skepticism about management's strategy, or—more seriously—that the announcement revealed or coincided with news of underlying financial weakness, a dilutive financing, or other undisclosed bad news not captured in these headlines. The stock's position as a 5 biggest loser suggests this was market-wide sentiment rather than a random tick. Without fuller context on the announcement details, investor call commentary, or simultaneous financial filings, the precise trigger remains unclear.

KLXER

KLX Energy Services Holdings, Inc. Rights

$0.02−$0.02

-52.8%

SOBR

SOBR Safe, Inc.Technology

$0.21−$0.18

-46.1%

NASDAQ · Mkt cap $1.6 M

No news headlines were found in the last 48 hours, so the 46% single-day drop cannot be directly attributed to a disclosed event. The move likely reflects a major negative catalyst not yet reported in the available news feed or a technical/liquidity event common in low-priced microcap stocks.

SOBR is a microcap stock trading at $0.21, and the absence of any news headlines in the 48-hour window surrounding a 46% crash is striking. For stocks in this price range, sharp intraday declines are often driven by one of several factors: delayed press release or regulatory filing that reaches the market before formal news wires pick it up, short-seller reports or social media rumors that precede headlines, reverse split or dilutive offering announcement, trading halt or delisting threat, or pure technical/liquidity capitulation in a thinly-traded security. Without headline data, we cannot distinguish between a genuine operational setback and a technical washout. The timing and magnitude suggest material adverse news likely exists but has not propagated to the Yahoo Finance RSS feed yet, or the market is reacting to something announced via company channels or SEC filings before mainstream coverage.

PGACR

$0.10−$0.07

-44.0%

LKSPR

Lake Superior Acquisition Corp. Rights - For Shares

$0.70−$0.50

-41.7%

NASDAQ

No news headlines were available in the last 48 hours to explain the 41.67% drop, so the cause remains unclear without additional context about LKSPR's structure or recent filings.

Lake Superior Acquisition Corp. Rights (LKSPR) is a SPAC rights offering, a security that trades based on the underlying warrant or acquisition dynamics of its parent SPAC. Without news headlines, several categories of catalyst are plausible. First, the SPAC may have announced or failed to announce an acquisition target by a deadline, triggering investor repricing. Second, broader market selloff or sector rotation in blank-check vehicles could have driven the decline. Third, technical factors such as redemption pressure, warrant conversion mechanics, or expiring rights deadlines could force repricing independent of fundamentals. Fourth, a delayed or negative regulatory ruling on the proposed merger could have emerged but not yet propagated to the news feed. Without specific information about LKSPR's current deal status, timeline, or market conditions, attributing the drop to any single cause is speculative.

CNTB

Connect Biopharma Holdings LimitedHealthcare

$1.17−$0.58

-33.3%

NASDAQ · Mkt cap $155 M

Connect Biopharma's Phase 2 asthma trial for Rademikibart showed lung function improvement but missed its primary endpoint of statistical significance in treatment failure reduction, triggering a 33% sell-off despite the 66% numerical reduction claimed.

The company announced preliminary Phase 2 data for Rademikibart in a global asthma trial that presented mixed results. While the drug achieved a statistically significant improvement in lung function at Day 7, the primary endpoint—a 66% reduction in treatment failure at 28 days—did not reach statistical significance. In biotech, missing a primary endpoint is typically a major negative catalyst, even when secondary or exploratory measures show promise. The market appears to have weighted the failure to achieve statistical significance heavily, signaling concern about the drug's viability and the likelihood of successful Phase 3 progression. The 33% drop reflects classic risk-off behavior in early-stage clinical-stage biopharma where endpoint achievement is binary and decisive for investor conviction.

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary SharesHealthcare

$2.93−$1.04

-32.4%

NASDAQ · Mkt cap $8.0 M

No news headlines were available in the last 48 hours to explain the 32.4% drop in CUPR stock, leaving the specific catalyst unknown.

The absence of any news in the last 48 hours makes it impossible to identify a definitive cause for this substantial decline. A 32% single-day loss typically reflects a material negative catalyst—such as an earnings miss, guidance reduction, clinical trial failure, regulatory setback, leadership change, or debt covenant breach—but none are documented in the available headlines. For a micro-cap equity like Cuprina Holdings trading at $2.93, price moves of this magnitude can also stem from low liquidity and high volatility that amplifies reaction to rumors, insider selling, or broad sector rotation, particularly in high-risk equity categories. Without additional information, it is only possible to infer that an unannounced event, delayed press release, or after-hours disclosure likely occurred before market hours or escaped the news feed sampled.

PFSA

Profusa, Inc.Healthcare

$1.84−$0.84

-31.3%

NASDAQ · Mkt cap $3.4 M

Profusa received a Nasdaq compliance determination letter on September 9, 2026, which likely triggered the 31% stock decline on announcement. The incomplete headline suggests a regulatory or listing status issue, though the full details are not disclosed in the available text.

The news headline references a Compliance Determination Letter from Nasdaq dated September 9, but the full text is truncated and does not reveal the specific nature of the compliance issue or determination outcome. This type of communication from an exchange typically addresses listing standards, financial deficiencies, or governance violations. For a biotech company trading at $1.84, potential triggers could include failure to maintain minimum bid price, shareholder equity requirements, or delayed financial filings. The market's 31% negative reaction suggests the determination was materially adverse, such as a delisting notice or cure period notification. Without the complete letter text, the precise violation and timeline for remediation remain unknown but clearly drove immediate selling pressure.

JAGX

Jaguar Health IncHealthcare

$0.22−$0.10

-30.1%

NASDAQ · Mkt cap $4.5 M

Jaguar Health announced a reverse stock split effective today, which typically signals financial distress and triggers selling pressure from investors concerned about the company's ability to maintain Nasdaq listing standards.

The company announced a reverse stock split, a corporate action that consolidates existing shares into fewer shares at higher per-share prices. While the headline does not disclose the split ratio or explicit reason, reverse splits are conventionally used by companies trading at very low prices to regain compliance with exchange minimum bid price requirements or to improve stock liquidity perception. The 30% single-day drop coinciding with the announcement suggests market participants view this as a negative signal of financial weakness rather than a neutral technical adjustment. Investors often sell ahead of or immediately upon reverse split implementation due to dilution concerns, the stigma associated with the action, and worry about future capital raises.

SWRD

Stewards, Inc

$1.94−$0.78

-28.7%

SWMR

SWARMER INCTechnology

$23.00−$9.13

-28.2%

NASDAQ · Mkt cap $452 M

Swarmer announced a pending acquisition of Ukrainian robotics firm Ratel with projections of $200M revenue in 2027, but the market sold off 28% today, suggesting investor skepticism about execution risk, valuation, or geopolitical concerns tied to the Ukrainian target.

The headline announces a positive corporate development—a planned acquisition with ambitious pro forma revenue and EBITDA targets for 2027. However, the 28% single-day decline indicates the market is discounting this news heavily. Possible explanations include concern about the acquisition's execution given Ratel's Ukrainian operations amid ongoing regional instability, skepticism about the $200M revenue and $20M EBITDA projections, questions about dilution or financing structure not detailed in the headline, or broader concern that management is overpaying or pursuing a risky international deal. The fact that this is described as a "pending" acquisition also suggests regulatory or closing uncertainty. Without additional details on valuation, financing terms, or market sentiment from the earnings call or investor materials, we cannot definitively isolate the specific trigger.

MGN

Megan Holdings LimitedIndustrials

$0.12−$0.05

-27.8%

NASDAQ · Mkt cap $3.7 M

MGN fell 27.84% with no news headlines in the past 48 hours, making the cause unclear; the drop may reflect a delayed market reaction, technical selling, or undisclosed company developments.

No news headlines were found in the past 48 hours to explain the sharp 27.84% decline in MGN stock. For a micro-cap stock trading at $0.12, typical catalysts for such moves include delayed earnings or financial results announcements, insider trading activity, regulatory filings, reverse splits, dilution events, or changes in company guidance that may not immediately surface on major financial news feeds. Without access to company filings, press releases, or social media activity beyond the provided RSS feed, it is impossible to determine whether this was a single large block trade, technical momentum breakdown, a rumored development circulating offline, or a response to broader sector weakness. The stock's penny-stock status and minimal float typical of such securities can amplify volatility on modest volume.

BENF

BeneficientFinancial Services

$0.60−$0.22

-26.6%

NASDAQ · Mkt cap $33 M

No news headlines were found in the last 48 hours, so the 26.58% decline cannot be attributed to a specific announced catalyst. The drop likely reflects a broader market event, technical selling, or unannounced negative development not yet covered by major newswires.

The absence of any news in the last 48 hours makes it impossible to identify a specific event that triggered this significant single-day loss. BENF is a microcap financial services company, and stocks in this category are often susceptible to technical selling, liquidity-driven moves, or delayed reporting of material events. The 26.58% drop is substantial and suggests either panic liquidation, a negative rumor circulating on social media or alternative channels, or an off-exchange announcement that has not yet reached mainstream financial news feeds. Without headline confirmation, we cannot determine whether the catalyst was company-specific (operational issue, insider selling, loss of a key client) or market-wide (sector rotation, broader credit concerns, or index rebalancing).

VSME

VS Media Holdings Limited - Class A Ordinary SharesCommunication Services

$0.99−$0.34

-25.6%

NASDAQ · Mkt cap $3.2 M

No news headlines are available in the last 48 hours to explain the 25.55% drop in VSME, so the cause remains unclear from public disclosures, though micro-cap media stocks often experience sharp moves on thin volume or delayed announcements.

The absence of any Yahoo Finance headlines in the last 48 hours is notable given VSME's 18th-largest decline today. This could indicate several scenarios: the catalyst occurred before the snapshot date and news dissemination lags, the move is driven by technical factors or low-volume trading rather than fundamental news, or an announcement was made through channels not captured in this particular news feed. VS Media is a micro-cap media holding company, and such securities are prone to volatile moves on relatively small trade volumes, insider activity, financing events, or delayed disclosure of business developments. Without concrete news, we cannot rule out intraday trading anomalies, margin pressure, or an off-exchange or after-hours development that has not yet filtered into mainstream financial headlines.

BHAVR

BHAV Acquisition Corp Rights

$0.15−$0.05

-25.0%

SLGB

Smart Logistics Global LimitedIndustrials

$0.33−$0.11

-24.3%

NASDAQ · Mkt cap $27 M

No news headlines were found in the last 48 hours, so the 24% drop cannot be attributed to a specific reported event; the cause likely falls into broad categories such as technical selling, market-wide pressure, or unannounced developments.

The absence of recent news makes it impossible to pinpoint a concrete catalyst for the sharp 24% decline in SLGB. For a micro-cap stock trading at $0.33, typical drivers of large single-day moves include broad market selloffs affecting small-cap equities, technical breakdown below key support levels, options expiration dynamics, short squeeze reversals, or unannounced company developments not yet reflected in public headlines. Micro-cap and penny stocks are also more susceptible to low-volume trading that can amplify price swings. Without a news trigger visible in the available data, the move remains unexplained by verifiable public information, leaving only speculation about underlying catalysts.

GTBP

GT Biopharma Inc.Healthcare

$9.00−$2.88

-24.2%

NASDAQ · Mkt cap $11 M

GT Biopharma announced positive FDA clearance and a new clinical trial indication for GTB-5550, yet the stock fell 24% on the same day, suggesting the market either priced in the news ahead of time, had higher expectations, or reacted to unstated contingencies like funding delays mentioned in the…

The headline news appears to be clinically and strategically positive: the company secured IND clearance from the FDA to test GTB-5550 in multiple myeloma, a significant blood cancer indication, and announced a new Phase 1 trial. However, the second headline contains a material caveat stating that trial initiation is contingent upon timing and receipt of non-dilutive grant funding, which could signal execution risk or capital constraints. The sharp 24% drop on positive-seeming news is atypical and suggests either the market had already incorporated the FDA clearance into the stock price before these releases went out, investor expectations were substantially higher, or the funding contingency is being read as a red flag about the company's ability to move forward independently. Without access to pre-announcement price action or forward guidance, it is difficult to determine definitively which factor dominated the sell-off.

ENVA

Enova International IncFinancial Services

$173.51−$53.44

-23.5%

NYSE · Mkt cap $4.5 B

Enova International withdrew its regulatory applications for the planned Grasshopper Bancorp acquisition on September 15, citing lack of clear banking standards and political pressure, triggering a 23.6% single-day sell-off despite reaffirmed financial guidance and announced faster buybacks.

The headlines establish a single, dominant catalyst: Enova's abrupt withdrawal of OCC and Federal Reserve applications for its bank charter acquisition. This represents a significant strategic reversal for a fintech company that had been pursuing regulatory approval to become a bank-holding entity. While management reaffirmed near-term growth forecasts and announced accelerated share repurchases to offset the decline, the market interpreted the withdrawal as a major setback to the company's long-term diversification and regulatory strategy. The CEO's public comments about absent clear standards and political pressure signal regulatory headwinds that extend beyond this single deal. The magnitude of the decline (ranking 22 worst performer of the day) reflects investor disappointment in a derailed acquisition and the broader uncertainty it creates around the company's regulatory pathway and competitive positioning in fintech lending.

AAC.WT

Ares Acquisition Corporation Re

$0.65−$0.20

-23.5%

RDACR

Rising Dragon Acquisition Corp. Rights

$0.08−$0.02

-23.2%

NASDAQ

No news emerged in the last 48 hours to explain the 23.20% drop in RDACR, a SPAC rights offering that likely moved on technical or market-structure factors affecting low-liquidity microcap securities.

Yahoo Finance returned no headlines in the 48-hour window, so the immediate catalyst cannot be identified from published news. RDACR is a rights offering associated with a blank-check acquisition vehicle, a category of security known for high volatility, thin trading volumes, and sensitivity to broader SPAC sentiment shifts or changes in the parent company's merger prospects. Rights typically trade on leverage and decay factors unrelated to daily news; declines of this magnitude in micro-cap instruments often reflect small share volume moves, margin pressure on holders, or deterioration in sentiment toward the SPAC sector or the specific target merger. Without concrete headlines, any explanation remains speculative, though technical factors or unannounced developments in the parent SPAC's deal timeline are plausible categories of cause.

PLCE

Children's Place Inc-TheConsumer Cyclical

$1.91−$0.58

-23.2%

NASDAQ · Mkt cap $54 M

The Children's Place fell 23% following Q2 2026 earnings on September 14, likely driven by disappointing financial results or guidance despite opening 19 new stores and reducing inventory.

The company reported second quarter 2026 results on September 14 after market close, which preceded the sharp 23% decline on September 15. The headline mentions two operational metrics: opening 19 new stores during the quarter and achieving a significant decrease in inventory balance compared to prior year. Both of these data points are typically positive signals—new store openings suggest expansion and inventory reduction often indicates improved inventory management or demand normalization. However, the headline is truncated and does not include critical financial metrics such as revenue, net income, comparable store sales, earnings per share, or forward guidance. The severity of the stock's decline suggests the actual earnings results or commentary fell well short of investor expectations, possibly indicating weak same-store sales, margin compression, or cautious forward guidance that overshadowed the operational positives. Without access to the full earnings release or management commentary, the specific financial disappointment cannot be pinpointed with certainty.

TONT.WT

Graf Global Corp.

$0.37−$0.11

-23.2%

ARMP

Armata Pharmaceuticals IncHealthcare

$4.37−$1.30

-22.9%

NYSE · Mkt cap $167 M

Armata Pharmaceuticals fell 22.88% on 2026-09-15 despite receiving FDA Breakthrough Therapy designation for AP-SA02 on 2026-09-14, suggesting investors sold on the news or profit-took after an 8% pre-announcement gain.

The timeline shows Armata announced FDA Breakthrough Therapy designation for AP-SA02 on September 14, which initially drove shares up 8%. However, by September 15, the stock had reversed sharply downward, losing 22.88% to rank among the day's largest losers. This pattern is consistent with a sell-the-news dynamic, where positive clinical or regulatory milestones trigger initial enthusiasm but then attract profit-taking or reveal that the market had already priced in the designation. Alternatively, investors may have digested details in the full announcement that dampened longer-term commercialization expectations, or broader biotech sector weakness on September 15 could have exacerbated the decline. Without intraday volume data, sector performance on that date, or commentary from the company or analysts, the precise trigger for the reversal remains unclear.

RBOT

D8 Holdings Corp.Healthcare

$0.03−$0.01

-22.9%

NYSE · Mkt cap $257 K

No news headlines were found in the last 48 hours, so the 22.88% drop cannot be directly attributed to a specific announced catalyst. This scale of decline in a penny stock typically reflects technical selling, liquidity events, or unconfirmed market rumors.

RBOT is a very low-priced stock trading at $0.03, which typically exhibits higher volatility and is more susceptible to technical moves, short covering reversals, or thin-volume selling. Without any recent news headlines to anchor an explanation, the decline could stem from several sources common to this category of security: forced liquidations or margin calls in retail accounts, a reversal of earlier momentum buying, deteriorating bid-ask spreads that amplify price moves on modest volume, or circulation of unconfirmed negative rumors on message boards or chat platforms that do not reach major news wires. Penny stocks also occasionally see sharp intraday reversals simply due to gap fills or the expiration of promotional interest. Without confirmatory reporting, attributing this move to any specific event would be speculation.

QLEP.WT

Quantum Leap Acquisition Corp WT

$0.12−$0.04

-22.6%

GTERR

Globa Terra Acquisition Corporation Rights

$0.05−$0.01

-22.3%

TAVIR

Tavia Acquisition Corp. Right

$0.09−$0.02

-21.6%

YMAT

J-STAR HOLDING CO LTDBasic Materials

$1.60−$0.43

-21.5%

NASDAQ · Mkt cap $7.3 M

No news headlines were found in the last 48 hours for YMAT, so the 21.50% single-day drop cannot be directly attributed to a public announcement or reported event.

The absence of any news in the Yahoo Finance RSS feed over the last 48 hours means we cannot point to a specific catalyst such as earnings, guidance, regulatory action, or corporate announcement. For a micro-cap stock like YMAT trading at $1.60, large single-day moves are not uncommon and can be driven by several mechanisms. Possible explanations include technical selling (triggered by chart breaks, stop-loss cascades, or broader market weakness on the date in question), a delayed news event that has not yet been widely distributed through major news channels, insider activity or regulatory filings that precede public disclosure, shifts in options positioning ahead of earnings or other events, or natural illiquidity in thinly traded securities amplifying normal trading imbalances. Without reporting to anchor on, all of these remain speculative.

GRNQ

Greenpro Capital CorpIndustrials

$9.79−$2.68

-21.5%

NASDAQ · Mkt cap $24 M

No news headlines were available in the last 48 hours to explain the 21.49% decline in GRNQ, suggesting the move may stem from a technical reversal, delayed news absorption, or sector-wide pressure.

The absence of recent news headlines in the provided data makes it impossible to identify a specific catalyst for the sharp 21.49% drop. For a microcap stock like Greenpro Capital Corp (GRNQ), declines of this magnitude often correlate with earnings misses, guidance cuts, insider selling disclosures, dilutive financing announcements, or broader fintech sector headwinds. Another possibility is that negative news broke outside the 48-hour window but is only now being priced in by the market, or that technical selling triggered by a breakdown of a key support level created momentum. Without access to the actual news that drove the move, the most honest assessment is that this represents a data gap rather than an identifiable fundamental catalyst based on the information provided.

BIAF

bioAffinity Technologies, Inc. Healthcare

$6.21−$1.68

-21.3%

NASDAQ · Mkt cap $3.3 M

No news headlines were published in the last 48 hours for BIAF, so the 21% decline likely stems from technical selling, a delayed announcement, or sector-wide biotech weakness rather than an identifiable catalyst.

The absence of recent news makes it impossible to pinpoint a specific event triggering the sharp 21% drop in BIAF stock. For small-cap biotechnology companies like bioAffinity Technologies, price moves of this magnitude are typically driven by clinical trial results, regulatory decisions from the FDA, partnership announcements, earnings surprises, or changes in guidance. Without headlines in the past 48 hours, the decline could reflect accumulated selling pressure from an announcement made earlier that is still reverberating, profit-taking after a prior run, sector rotation away from biotech, or technical weakness in the stock's chart. It is also possible that a material announcement has been made but has not yet been indexed by the news feed provided. Given BIAF's small market cap and lower liquidity typical of microcap biotech stocks, price volatility and moves disconnected from news are not uncommon.

BMGL

Basel Medical Group Ltd Ordinary SharesHealthcare

$5.70−$1.53

-21.2%

NASDAQ · Mkt cap $8.1 M

No news headlines were found in the last 48 hours for BMGL, so the 21% drop cannot be directly attributed to a specific announced event. The cause likely involves sector weakness, technical selling, or untracked developments outside the headline sources provided.

The absence of news in the Yahoo Finance RSS feed over the past 48 hours makes it impossible to identify a concrete catalyst for the sharp 21% decline. For a small-cap or micro-cap medical device company like Basel Medical Group, typical drivers of such moves include clinical trial results or setbacks, FDA regulatory actions or rejections, changes in management or guidance, loss of a significant partnership or contract, or broader sector selloffs in medical technology stocks. It is also possible the move reflects delayed market reaction to news published earlier, technical trading pressure, or rumors circulating outside major news channels. Without verifiable headlines, we cannot determine which category applies.

NUR

Nuran Wireless Inc.

$1.18−$0.28

-20.4%

USDE

StablecoinX Inc.Financial Services

$6.11−$1.50

-20.4%

NASDAQ · Mkt cap $74 M

No financial news or headlines were found in the last 48 hours despite a sharp 20.41% single-day decline, making the specific catalyst unknown. This magnitude of move in a stablecoin-linked equity typically suggests a market-moving event, technical breakdown, or undisclosed news.

The absence of any headlines in the last 48 hours is notable given the severity of the decline—a 20% drop ranks USDE as the 37th biggest loser of the day on NASDAQ. For a company explicitly tied to stablecoins, the most likely categories of hidden catalyst include: first, a regulatory action or disclosure of compliance issues affecting the stablecoin operations themselves, which may not immediately surface in tracked news feeds; second, a technical event such as a depegging, reserve shortfall, or liquidity crisis in the underlying stablecoin product, which could trigger institutional redemptions and equity selloff; and third, an unconfirmed rumor or after-hours announcement not yet captured by standard news aggregators. Stablecoin equities are particularly sensitive to trust and operational transparency, so even partial loss of confidence can drive outsized moves. Without headline confirmation, any explanation remains speculative.

ILLR

Triller Group Inc.Technology

$0.60−$0.15

-20.0%

NASDAQ · Mkt cap $20 M

No news headlines were available in the last 48 hours to explain the 20% drop in ILLR stock, so the cause remains unclear without additional information.

Triller Group Inc. experienced a significant 20.05% decline to $0.60 on September 15, 2026, but no news headlines from the last 48 hours are available to identify a specific catalyst. This is a material gap in the evidence. For a stock trading at such a low price point, common drivers of sudden drops include technical selling pressure, margin calls or forced liquidations, insider selling announcements, delayed negative earnings or guidance revisions that weren't captured in the news feed, unannounced changes in financing status, or broader sector rotation in social media or entertainment stocks. Without headlines or structural information about recent events at the company, it is not possible to pinpoint which of these categories applies or whether the move reflects a company-specific event versus broader market dynamics.

QCLS

Q/C Technologies, Inc.

$0.45−$0.11

-20.0%

BTCT

Btc Digital Ltd.Technology

$1.23−$0.31

-19.9%

NASDAQ · Mkt cap $14 M

BTCT fell 19.88% on the same day Tianci International announced a crypto computing partnership with BTC Digital, though the headline provided does not clearly explain why this strategic cooperation triggered a selloff.

The only headline in the 48-hour window is Tianci International's announcement of a memorandum of understanding with BTC Digital for a 3 MW crypto computing project. This is nominally positive news for a crypto-focused company, yet BTCT dropped nearly 20 percent on that same day. The headline text is incomplete, so we cannot assess whether the MOU contained dilutive terms, disappointing scale, or unfavorable partnership economics that would justify selling. Alternatively, the drop may be unrelated to this news entirely—perhaps driven by broader crypto market weakness, short covering, or unrelated company-specific developments not captured in the headlines provided. Without more complete information about the partnership terms or broader market context, the precise catalyst remains unclear.

ALHC

Alignment Healthcare, Inc.Healthcare

$10.41−$2.51

-19.4%

NASDAQ · Mkt cap $2.8 B

Alignment Healthcare tumbled 19.43% after management's vague response to star ratings questions on Tuesday, compounding existing skepticism from its second-quarter results and reinforcing investor concern about insurer fundamentals.

The headline points to a specific trigger: management's "Don't Poke the Bear" silence on star ratings during what appears to be an earnings call or investor event on September 15. Star ratings are critical to Medicare Advantage insurers because they directly affect revenue and enrollment. Management's refusal to address this question suggests either poor ratings, deteriorating performance, or defensive posturing—all red flags. The article notes this reinforced skepticism already present from the Q2 report, indicating this is not an isolated event but part of a deteriorating narrative. The stock was already under pressure, and this evasive commentary appears to have triggered a capitulation. CLOV's correlated fall suggests sector-wide weakness among MA insurers, though the primary driver here is ALHC-specific management communication failure.

IOTR

iOThree Limited Ordinary SharesCommunication Services

$1.61−$0.38

-19.4%

NASDAQ · Mkt cap $13 M

No news headlines were available in the last 48 hours to explain the 19.36% drop in IOTR, so the cause remains unclear without additional context or access to company announcements.

iOThree (IOTR) fell nearly 20% on September 15 with zero headlines identified in the search window. This absence of news does not rule out a catalyst, but it means the move is not attributable to a widely-reported public announcement or earnings event captured by major financial outlets. Possible explanations in such cases include delayed disclosure of company news not yet indexed by RSS feeds, technical selling or short-covering, sector rotation, an unconfirmed rumor or social media catalyst, or a material announcement made through the company's own channels before wire distribution. Without access to the company's investor relations page or SEC filings dated September 15, the specific driver cannot be identified. Micro-cap and small-cap stocks like IOTR are also more prone to liquidity-driven moves and low-volume volatility.

PLAY

Dave & Buster's Entertainment IncCommunication Services

$6.86−$1.64

-19.3%

NASDAQ · Mkt cap $347 M

Dave & Buster's reported Q2 revenue that missed analyst estimates, swung to a net loss, and posted weak earnings, triggering a 19% sell-off despite management signaling improving trends ahead.

The headlines establish that PLAY reported second-quarter results on September 14 that fell short of expectations on both top and bottom lines. Revenue declined 2.4% year-over-year to $544.1 million, missing the consensus estimate by approximately 3%. More critically, the company swung to a $12.5 million net loss after earnings, with a non-GAAP loss of $0.27 per share representing a 242% negative earnings surprise relative to analyst consensus. Management disclosed the company is pursuing $30 million in cost-savings initiatives and attributed weakness to pressure from lower-income consumers. However, management also noted same-store sales trends improved during July and early Q3, and same-store sales declines eased in the quarter, which management characterized as potentially changing the story for investors. The 19% decline reflects the magnitude of the earnings miss outweighing the forward-looking commentary about trend stabilization.

APUS

Apimeds Pharmaceuticals US, IncHealthcare

$1.66−$0.38

-18.8%

NYSE · Mkt cap $6.0 M

No news headlines were available in the last 48 hours to explain the 18.77% drop in APUS stock, so the cause remains unclear from publicly reported events.

The absence of recent news makes it impossible to identify a specific catalyst for the decline. For a small-cap pharmaceutical stock like Apimeds, significant intraday moves can stem from several sources: delayed earnings or clinical trial results released after news cycles close, internal company announcements made via SEC filings rather than press releases, shifts in sector sentiment affecting smaller biotech plays, short-covering or technical liquidation, or unconfirmed rumors circulating in specialized investment communities. Without access to SEC filings, conference calls, or other official disclosures made on September 15, 2026, the actual trigger cannot be determined. The stock's current price of $1.66 suggests it may already be highly distressed, which could amplify volatility independent of new information.

OLB

The OLB Group, Inc.

$0.21−$0.05

-18.7%

DVLT

Datavault AI IncTechnology

$0.16−$0.04

-18.7%

NASDAQ · Mkt cap $253 M

Datavault AI shares fell 18.67% despite announcing a landmark purchase order, likely weighed down by ongoing shareholder litigation notices that are damaging investor confidence and overshadowing the positive commercial news.

The headline evidence reveals a mixed picture. On the positive side, DVLT announced a landmark commercial purchase order on the day of the drop, which would normally be expected to support the stock. However, the first headline explicitly states that shares are slipping "despite" this announcement, citing "ongoing shareholder litigation notices" as a significant headwind. The second headline discusses CyberCatch's management information circular related to DVLT's previously announced acquisition, suggesting the deal is progressing through regulatory steps. The litigation appears to be the dominant negative factor overwhelming the positive order announcement. At an all-time low of $0.16, the stock may also be facing technical selling pressure and liquidity challenges typical of heavily distressed microcaps. The combination of litigation risk and deal uncertainty likely explains why a new customer win failed to lift sentiment.

NIXX

Nixxy, Inc.Communication Services

$0.43−$0.10

-18.5%

NASDAQ · Mkt cap $21 M

No headlines were found in the last 48 hours to explain Nixx's 18.46% drop, so the cause remains unclear; typical micro-cap declines like this can stem from earnings disappointments, insider selling, technical breakdown, or delayed news dissemination.

The absence of any news headlines in the Yahoo Finance RSS feed over the past 48 hours means the stated catalyst for the 18.46% decline cannot be established from available reporting. Nixx trades at $0.43, suggesting it is a micro-cap or penny stock, a category known for volatility and thin liquidity that can amplify moves on modest volume. Possible explanations include an earnings release or guidance cut that has not yet propagated to major headlines, insider selling or Form 4 filings, a technical breakdown below support, broker rating downgrades with limited coverage, or delayed news from company filings or conference calls. Without confirmation from news sources, any specific attribution would be speculation. The ranking as the 47th biggest loser indicates genuine price action but does not clarify the underlying reason.

NSAIR

NorthStrive Acquisition Corp I. Rights

$0.15−$0.03

-17.7%

LHSW

Lianhe Sowell International Group Ltd Ordinary SharesTechnology

$0.55−$0.11

-17.6%

NASDAQ · Mkt cap $9.6 M

No news headlines were found in the last 48 hours, so the 17.55% drop cannot be attributed to a specific announced event; the cause likely falls into technical selling, delayed news, or broader sector pressure.

The absence of any headlines in the last 48 hours makes it impossible to tie this decline to a named catalyst such as earnings, guidance, regulatory action, or corporate development. A micro-cap NASDAQ stock like LHSW trading at $0.55 can be sensitive to several other drivers: thin liquidity and algorithmic selling into low volume, short-term technical breaks below support levels, delayed negative news that has not yet appeared in major RSS feeds, sector-wide pullback in small-cap or international equities, or rumor-based selling. Without access to intraday trading patterns, short interest data, or contemporaneous social media discussion, the specific mechanism remains unknown. The rank as 49th biggest loser suggests this was a material percentage move in absolute terms, even though the dollar amount was small.

AXINR

Axiom Intelligence Acquisition Corp 1 Right

$0.28−$0.06

-17.4%

NASDAQ

No news headlines were found in the last 48 hours, but AXINR is a SPAC rights unit that typically experiences volatility tied to merger negotiations, redemption rates, and sponsor confidence rather than operational events.

The absence of any news in the past 48 hours makes it difficult to pinpoint a specific catalyst for the 17.45% decline. However, AXINR is a rights component of a special purpose acquisition company structure, which means its value is highly sensitive to investor confidence in the pending merger, redemption announcements, or changes in deal terms. Rights units are particularly volatile instruments because they represent claims on a specific number of shares post-merger at predetermined prices. Declines in this category of security often reflect either (1) a negative update on merger timing or valuation that may not yet have appeared in public news feeds, (2) elevated redemption rates signaling shareholder skepticism, or (3) broader weakness in SPAC sentiment. Without concrete news, the move cannot be confidently attributed to any single event.